Vitamin D plays a crucial role in supporting lung function, preventing respiratory infections, and reducing inflammation.

This progressive lung disease transforms healthy tissue into stiff, scarred areas making breathing difficult. Learn the ...

In March 2025, Vertex Pharmaceuticals Incorporated announced a study is to evaluate the safety, and tolerability and efficacy ...

Data from pivotal Phase 3 trial in CHB-associated liver fibrosis expected in Q2 2025 Commercial launch ... to modify the progression of chronic obstructive pulmonary disease (“COPD”), is undergoing ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study.

Early research shows a one-time gene therapy has potential for addressing both the liver and lung disease that patients with ...

The DWP's PIP benefits are still available despite potential changes and could get you £812 a month if you have one of these ...

Post-COVID pulmonary fibrosis, which involves scarring of the lungs that can worsen over time and may require a lung transplant, affects some patients after infection, according to pulmonologists.

Beam Therapeutics reported promising Phase 1/2 data for BEAM-302, demonstrating durable gene correction for AATD. See why I ...

The investigators searched the American version of YouTube for videos in English, from 2004 to July 2024, concerning PR on non-COPD conditions (such as interstitial lung disease, pulmonary arterial ...